You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck

  • Technology appraisal guidance
  • Reference number: TA145
  • Published:  25 June 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Expert comments on the ACD

  • Head and neck cancer: Final appraisal determination - Let's face it

  • Head and neck cancer: Final appraisal determination - Merck Pharmaceuticals

  • Head and neck cance: Final appraisal determination - Royal College Nursing

  • Head and neck cancer: Final appraisal determination - Royal College of Pathologists

  • Head and neck cancer: Final appraisal determination - British Association of Head and Neck Oncologists

  • Head and neck cancer: Final appraisal determination - King's College Hospital Maxilliofacial Unit - The Head and Neck Oncology Group


This page was last updated: 30 March 2010

Back to top